Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Abbott's new LHRH antagonists, pharmaceutical compositions and use

Nov. 26, 1999

Novel antitumor agents for both leukemias and solid tumors discovered by Taiwanese scientists

Nov. 26, 1999

Xenova's IND for multidrug resistance modulator gets FDA approval

Nov. 26, 1999

AACR-NCI-EORTC news: Japanese research team presents new hypoxic cell radiosensitizing agent

Nov. 25, 1999

Mount Sinai investigators describe novel apoptosis-inducing agent at scientific forum

Nov. 25, 1999

BASF discloses protein kinase inhibitors useful as antiangiogenic agents

Nov. 25, 1999

Calcium entry blockers with potential in the treatment of prostate cancer

Nov. 25, 1999

Valentis initiates phase IIa trial of IFN-alpha gene medicine in angiosarcoma

Nov. 25, 1999

Combination therapy containing GTI-2040 shows remarkable antitumor activity

Nov. 25, 1999

More promising cancer news from AACR-NCI-EORTC: Hughes Institute presents new compounds

Nov. 24, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...